World's Best Scientists 2026 revealed!
William V. Tamborlane

William V. Tamborlane

D-Index & Metrics

Medicine

D-Index
133
Citations
67292
World Ranking
2223
National Ranking
1255

William V. Tamborlane publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where William V. Tamborlane sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 568 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

William V. Tamborlane D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where William V. Tamborlane sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 133 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

William V. Tamborlane is affiliated with Yale University in the United States. Their research predominantly focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with substantial contributions in the subfields of Endocrinology, Diabetes and Metabolism, Surgery, Genetics, Cardiology and Cardiovascular Medicine, and Molecular Biology.

The scientist's research topics cover a range of areas related to diabetes, including:

  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Diabetes Treatment and Management
  • Metabolism, Diabetes, and Cancer
  • Diet and metabolism studies
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients

Key recent publications include:

  • Once-Weekly Exenatide in Youth With Type 2 Diabetes, 2022, Diabetes Care
  • Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study, 2022, The Lancet Diabetes & Endocrinology
  • Impact of Type 1 Diabetes in the Developing Brain in Children: A Longitudinal Study, 2021, Diabetes Care
  • American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update, 2022, Endocrine Practice
  • Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial, 2023, The Lancet Diabetes & Endocrinology

Frequent coauthors in the scientist's body of work include:

  • Michelle Van Name
  • Lori M. Laffel
  • Georgeanna J. Klingensmith
  • Steven M. Willi
  • Neil H. White

William V. Tamborlane has published extensively in several academic venues, most notably:

  • Diabetes (14 publications)
  • Diabetes Care (11 publications)
  • Diabetic Medicine (3 publications)
  • Endocrine Practice (2 publications)
  • The Lancet Diabetes & Endocrinology (2 publications)

In addition to peer-reviewed journal articles, the scientist has contributed to book publications, including a work titled Diabetes in Children and Adolescents, published by Springer International Publishing in 2021.

Best Publications

  • Obesity and the Metabolic Syndrome in Children and Adolescents

    Ram Weiss;James Dziura;Tania S. Burgert;William V. Tamborlane

  • Prevalence of Impaired Glucose Tolerance among Children and Adolescents with Marked Obesity

    Ranjana Sinha;Gene Fisch;Barbara Teague;William V Tamborlane

  • Continuous glucose monitoring and intensive treatment of type 1 diabetes.

    Tamborlane Wv;Beck Rw;Bode Bw

  • International Consensus on Use of Continuous Glucose Monitoring

    Thomas Danne;Revital Nimri;Tadej Battelino;Richard M. Bergenstal

  • State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

    Nicole C Foster;Roy W Beck;Kellee M Miller;Mark A Clements

  • Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

    Kellee M. Miller;Nicole C. Foster;Roy W. Beck;Richard M. Bergenstal

  • Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

    Stephanie A. Amiel;Robert S. Sherwin;Donald C. Simonson;Albert A. Lauritano

  • Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

    Richard M. Bergenstal;William V. Tamborlane;Andrew Ahmann;John B. Buse

  • Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort

    H. Shamoon;P. Cleary;A. Barnie;S. Genuth

  • Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial.

    Mary Savoye;Melissa Shaw;James Dziura;William V. Tamborlane

  • Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life.

    Margaret Grey;Elizabeth A. Boland;Maryanne Davidson;Ju Li

  • Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas

    Stuart A Weinzimer;Garry M Steil;Karena L Swan;Jim Dziura

  • Limitations of Conventional Methods of Self-Monitoring of Blood Glucose: Lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes

    Elizabeth Boland;Teresa Monsod;Maria Delucia;Cynthia A. Brandt

  • Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

    Richard M. Bergenstal;Satish Garg;Stuart A. Weinzimer;Bruce A. Buckingham

  • Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning.

    Ram Weiss;Sylvie Dufour;Sara E Taksali;William V Tamborlane

  • Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.

    E A Boland;M Grey;A Oesterle;L Fredrickson

  • Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.

    Satish K Garg;Stuart A Weinzimer;William V Tamborlane;Bruce A Buckingham

  • Reduction to Normal of Plasma Glucose in Juvenile Diabetes by Subcutaneous Administration of Insulin with a Portable Infusion Pump

    William V. Tamborlane;Robert S. Sherwin;Myron Genel;Philip Felig

  • Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline

    Kenneth C. Copeland;Philip Zeitler;Mitchell Geffner;Cindy Guandalini

  • Effect of Intensive Insulin Therapy on Glycemic Thresholds for Counterregulatory Hormone Release

    Stephanie A Amiel;Robert S Sherwin;Donald C Simonson;William V Tamborlane

Frequent Co-Authors

Roy W. Beck
Roy W. Beck University of South Florida
Robert S. Sherwin
Robert S. Sherwin Yale University
Sonia Caprio
Sonia Caprio Yale University
Bruce A. Buckingham
Bruce A. Buckingham Stanford University
Linda A. DiMeglio
Linda A. DiMeglio Indiana University
James Dziura
James Dziura Yale University
Neil H. White
Neil H. White Washington University in St. Louis
Timothy W. Jones
Timothy W. Jones Tennessee Department of Health
Lori M.B. Laffel
Lori M.B. Laffel Harvard Medical School
Philip Felig
Philip Felig Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a traditional MD in the USA is not the only route to a rewarding healthcare career. Many students explore flexible alternatives such as online degrees to enter the booming health sector. Programs like an affordable healthcare administration degree online provide a foundation in management and policy, preparing graduates for leadership positions in hospitals and clinics.

For those seeking advanced leadership roles, a master's in healthcare administration online offers further specialization in administration and strategy, while remaining accessible for working professionals.

Nursing professionals can accelerate their careers through the best online bsn to dnp programs, moving straight from a BSN to a Doctor of Nursing Practice degree and qualifying for top clinical and leadership roles.

Alternatively, the 3 year online pharmd makes entry into pharmacy practice more accessible for busy students. Exploring these pathways can help you find the right fit in healthcare, whether you’re drawn to patient care, administration, or advanced clinical roles.

Best Scientists Citing William V. Tamborlane

Trending Scientists

Recently Published Articles